delete PART 1301—REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, AND DISPENSERS OF CONTROLLED SUBSTANCES
This regulation establishes a comprehensive DEA registration system requiring all manufacturers, distributors, dispensers, importers, exporters, and researchers of controlled substances to obtain pre-approval before engaging in any controlled substance activities. It dictates application procedures, fee structures, renewal cycles (3 years for most), location-specific requirements, security provisions, special rules for online pharmacies and mobile treatment programs, and mandates coordination with state licensing through affidavits. The system creates a bureaucratic barrier to entry for any legitimate controlled substance handling.
This registration regime imposes crushing compliance costs that fall disproportionately on small pharmacies, practitioners, and researchers while protecting incumbent corporations from competition. It stifles potentially life-saving medical research on Schedule I substances through onerous protocols, and its online pharmacy rules inhibit telemedicine innovation. The hidden tax of regulatory compliance burden exceeds any marginal benefit in diversion prevention, which could be achieved through targeted enforcement against actual illegal activity rather than pre-approval bureaucracy. The complexity violates rule of law principles and represents federal overreach into areas that states could regulate more efficiently.